He noted that trials that combine neuroimaging techniques that measure the blood-brain barrier and GLP-1 treatment are needed and could prove that these drugs have neuroprotective benefits.

Here are those guidelines: 1. Remember, “No feeling is final.” I can’t take credit for this quotation. It’s from the poet Rilke. His reflection on impermanence has been incredibly helpful ...

In treatment-resistant bipolar depression ... It’s considered a second-line therapy by Canadian guidelines for treating bipolar 1 depression. However, there are concerns about modafinil ...

A 25-year-old woman with type 1 diabetes has been able to stop taking insulin after a groundbreaking stem cell treatment. This is the first human trial of the procedure, and while it’s too soon ...

While most people will experience a period of sadness in their life, depression can be more challenging with bipolar disorder because there’s fewer treatment options and the lows tend to be very ...

Nonadherence to treatment frequently results, leading to mental health decompensation. In recent years, studies examining the use of semaglutide and other (GLP-1) agonists (e.g., luraglutide ...

The World Health Organization (WHO) evidence-based global Guidelines on Physical Activity, Sedentary Behavior and Sleep for Children Under 5 Years of Age, recommends that children aged three to ...

BEIJING, Sept 30 — Chinese scientists have announced the world’s first successful case of using cell transplants to treat type 1 diabetes. The patient ... islet cells from a deceased donor and ...

Her parents got her into mental health treatment ... of its bipolar population, at around 3 percent, are higher than those of Australia, where the estimate is around 2.1 percent, and Europe ...

Trileptal (oxcarbazepine) is an anticonvulsant drug approved by the U.S. Food and Drug Administration (FDA) to treat epilepsy. However, some may take it off-label (meaning for a use the FDA has not ...